Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Arjunin
- Development stage
- Unknown
- Lead developer
- Charak
- Administration
- Oral
01
Overview
Arjunin is a proprietary Ayurvedic formulation developed by Charak Pharma to support cardiovascular health. It is primarily composed of Arjuna (*Terminalia arjuna*), a well-known cardioprotective herb that exhibits antianginal, hypolipidemic, and antioxidant properties. The formulation also contains other synergistic herbs such as Punarnava (*Boerhaavia diffusa*), Jatamansi (*Nardostachys jatamansi*), Draksha (*Vitis vinifera*), and Amra (*Mangifera indica*). Arjunin is marketed as an oral capsule and is used as a supportive therapy for managing mild to moderate hypertension, hyperlipidemia, angina, and overall cardiac wellness by improving blood circulation and strengthening cardiac muscles.
- Brand names
- Arjunin
- Other names
- Arjunin CapsuleArjunin Capsules
Beyond the preview
Go deeper on Arjunin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Arjunin.